Nephro Care Financial Statements
Nephro Care financial statements. In FY2026, Nephro Care (NEPHROCARE) reported revenue ₹28 Cr, net profit ₹1 Cr and EPS ₹0.61, with a net profit margin of 3.6% and ROE of 1.8%. Full financial statements from FY2025 to FY2026 (2 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see NEPHROCARE share price screener.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
NEPHROCARE Revenue, Net Profit & EBITDA — Year-on-Year Growth
NEPHROCARE YoY (Jun 2025 vs Mar 2026) — revenue +64.7%, net profit +200.0%, EBITDA +200.0%, expenses +47.1%. Read NEPHROCARE dividend payout details for the complete payout history and dividend yield track record.
NEPHROCARE Income Statement — Revenue, EBITDA & Net Profit
Nephro Care revenue ₹28 Cr, EBITDA ₹3 Cr, net profit ₹1 Cr, EPS ₹0.61 (2026) — net profit margin 3.6%. Analyse NEPHROCARE institutional holdings to track promoter, FII and institutional holdings.
| Particulars | Mar 2026 | Jun 2026 | Jun 2025 |
|---|---|---|---|
| Revenue | 28 | 29 | 17 |
| Expenses | 25 | 26 | 17 |
| EBITDA | 3 | 4 | 1 |
| Operating Profit Margin % | 8.00% | 12.00% | 3.00% |
| Depreciation | 2 | 1 | 1 |
| Interest | 0 | 0 | 0 |
| Profit Before Tax | 1 | 3 | -1 |
| Tax | 0 | 1 | 0 |
| Net Profit | 1 | 2 | -1 |
| Earnings Per Share (₹) | 0.61 | 0.98 | -0.39 |
NEPHROCARE Balance Sheet — Assets, Liabilities & Shareholders' Equity
NEPHROCARE total assets ₹73 Cr, total equity ₹57 Cr, total liabilities ₹ Cr (2026) — ROE 1.8%.
| Particulars | 2026 |
|---|---|
| ASSETS | |
| Total Assets | 73 |
| Current Assets | 31 |
| Fixed Assets | 34 |
| Capital Work in Progress | 1 |
| Investments | 10 |
| Other Assets | 28 |
| LIABILITIES | |
| Total Liabilities | |
| Current Liabilities | 1 |
| Non-Current Liabilities | |
| SHAREHOLDERS' EQUITY | |
| Total Equity | 57 |
| Share Capital | 17 |
| Reserves & Surplus | 40 |
NEPHROCARE Cash Flow Statement — Operating, Investing & Financing
Nephro Care operating cash flow ₹2 Cr, investing ₹0 Cr, financing ₹0 Cr, net cash flow ₹2 Cr (2026).
| Particulars | March 2026 |
|---|---|
| Operating Activities | 2 |
| Investing Activities | 0 |
| Financing Activities | 0 |
| Net Cash Flow | 2 |